Company / SG&A Expense
Prestige Consumer Healthcare SG&A Expense History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$106.2M
FY2026
5-year range
$83.1M / $108.2M
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#111 of 213
Health Care
What the data says
At $106M, Prestige Consumer Healthcare's sg&a expense ranks #103 of 213 in the Health Care sector. SG&A Expense has fluctuated over the past 9 years, ranging from $72M in FY2018 to $108M in FY2024.
Based on SEC 10-K filings.
$106M in FY2026 with a 5-year CAGR of +3.4%.
Increased from $83M to $106M over the past 3 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +8.5%
- 5-Year CAGR
- +3.4%
- 10-Year CAGR
- -
Sector benchmark
#103 of 213 in Health CareTop 48% of 213This company $106.2M Sector average $722.3M
▼
-85.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.4%, indicating consistent growth.
- Ranks #111 out of 213 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2024.
- Lowest sg&a expense in the period was in FY2018.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $106.2M | - |
| FY2025 | - | - |
| FY2024 | $108.2M | +30.2% |
| FY2023 | $83.1M | -6.7% |
| FY2022 | $89.1M | -0.7% |
| FY2021 | $89.8M | +5.1% |
| FY2020 | $85.4M | -4.2% |
| FY2019 | $89.1M | +23.1% |
| FY2018 | $72.4M | -15.2% |
| FY2017 | $85.4M | -4.2% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026